RARE
RARE
US90400D1081
Ultragenyx Pharmaceutical Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
1.53B EUR
3.29B EUR
2.06B EUR
2.22B EUR
Enterprise Value
2.42B EUR
3.17B EUR
1.88B EUR
1.83B EUR
Valuation Multiples
Trailing P/E
--
--
--
--
Forward P/E
26.12x
--
--
--
Price to Sales
2.13x
4.59x
3.07x
4.15x
Price to Book
--
--
--
--
EV/Revenue
3.38x
4.42x
2.81x
3.43x
EV/EBITDA
-5.2x
--
--
--
Price to FCF (P/FCF)
--
--
--
--
EV/FCF
--
--
--
--
FCF Yield
-14.53%
-15%
-24.66%
-13.75%
ende